Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The role of cholecystokinin in the induction of aggressive behavior: a focus on the available experimental data (review).

Katsouni E, Zarros A, Skandali N, Tsakiris S, Lappas D.

Acta Physiol Hung. 2013 Dec;100(4):361-77. doi: 10.1556/APhysiol.100.2013.4.1. Review.

PMID:
24317345
2.

Neuropeptides and anxiety: focus on cholecystokinin.

Lydiard RB.

Clin Chem. 1994 Feb;40(2):315-8. Review.

3.

Biological actions of cholecystokinin.

Crawley JN, Corwin RL.

Peptides. 1994;15(4):731-55. Review.

PMID:
7937354
4.

Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.

Hebb AL, Poulin JF, Roach SP, Zacharko RM, Drolet G.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1225-38. Epub 2005 Oct 20. Review.

PMID:
16242828
5.

Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.

Miczek KA, Fish EW, De Bold JF, De Almeida RM.

Psychopharmacology (Berl). 2002 Oct;163(3-4):434-58. Epub 2002 Aug 6. Review.

PMID:
12373445
6.
7.

Cholecystokinin in psychiatric research: a time for cautious excitement.

Abelson JL.

J Psychiatr Res. 1995 Sep-Oct;29(5):389-96. Review.

PMID:
8748063
8.

Two faces of cholecystokinin: anxiety and schizophrenia.

Bourin M, Malinge M, Vasar E, Bradwejn J.

Fundam Clin Pharmacol. 1996;10(2):116-26. Review.

PMID:
8737954
9.

Cholecystokinin and anxiety: promises and pitfalls.

Rodgers RJ, Johnson NJ.

Crit Rev Neurobiol. 1995;9(4):345-69. Review.

PMID:
8829850
10.

Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.

Kõks S, Männistö PT, Bourin M, Shlik J, Vasar V, Vasar E.

J Psychiatry Neurosci. 2000 Jan;25(1):33-42.

11.

The involvement of substance P in the induction of aggressive behavior.

Katsouni E, Sakkas P, Zarros A, Skandali N, Liapi C.

Peptides. 2009 Aug;30(8):1586-91. doi: 10.1016/j.peptides.2009.05.001. Epub 2009 May 13. Review.

PMID:
19442694
13.

Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats.

Panksepp J, Burgdorf J, Beinfeld MC, Kroes RA, Moskal JR.

Brain Res. 2004 Oct 29;1025(1-2):75-84.

PMID:
15464747
14.

Release of cholecystokinin in the central nervous system.

Raiteri M, Paudice P, Vallebuona F.

Neurochem Int. 1993 Jun;22(6):519-27. Review.

PMID:
8513278
15.

Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.

Hernandez-Gómez AM, Aguilar-Roblero R, Pérez de la Mora M.

Amino Acids. 2002;23(1-3):283-90.

PMID:
12373548
16.

Major biological actions of CCK--a critical evaluation of research findings.

Fink H, Rex A, Voits M, Voigt JP.

Exp Brain Res. 1998 Nov;123(1-2):77-83. Review.

PMID:
9835394
17.

Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

Harro J, Vasar E.

Neurosci Biobehav Rev. 1991 Winter;15(4):473-7. Review.

PMID:
1792008
18.

Cholecystokinin and learning and memory processes.

Hadjiivanova C, Belcheva S, Belcheva I.

Acta Physiol Pharmacol Bulg. 2003;27(2-3):83-8. Review.

PMID:
14570153
19.

Neuroanatomical circuits modulating fear and anxiety behaviors.

Charney DS.

Acta Psychiatr Scand Suppl. 2003;(417):38-50. Review.

PMID:
12950435
20.

Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists.

Hughes J, Hunter JC, Woodruff GN.

Neuropeptides. 1991 Jul;19 Suppl:85-9. Review. No abstract available.

PMID:
1679213

Supplemental Content

Support Center